Login / Signup

Personalized approaches for treatment-naïve mantle cell lymphoma.

David A QuallsAnita Kumar
Published in: Expert review of hematology (2023)
Given the wide array of disease and patient presentations with MCL, a personalized therapeutic approach is needed to optimize outcomes. The optimal therapeutic strategy should incorporate disease prognostic factors, patient status and comorbidities, goals of care, and response to treatment.
Keyphrases
  • prognostic factors
  • case report
  • healthcare
  • palliative care
  • high throughput
  • metabolic syndrome
  • adipose tissue
  • mass spectrometry
  • combination therapy
  • pain management
  • single cell
  • glycemic control
  • affordable care act